We are live on
!
Find out more
EPM
Equitec Proprietary Markets Portfolio holdings
AUM
$187M
1-Year Est. Return
179.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+179.87%
3 Year Est. Return
+470.49%
5 Year Est. Return
+544.99%
10 Year Est. Return
–
AUM
$326M
AUM Growth
-$99.3M
(-23%)
Cap. Flow
-$97.2M
Cap. Flow
% of AUM
-29.8%
Top 10 Holdings %
Top 10 Hldgs %
68.61%
Holding
112
New
14
Increased
26
Reduced
25
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$14.5M |
| 2 |
OA
Orbital ATK, Inc.
OA
|
+$3.74M |
| 3 |
GE Aerospace
GE
|
+$3.37M |
| 4 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$1.92M |
| 5 |
IXYS
IXYS Corp
IXYS
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$27.6M |
| 2 |
Tesla
TSLA
|
+$8.63M |
| 3 |
ALR
Alere Inc
ALR
|
+$4.19M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$3.39M |
| 5 |
SYT
Syngenta Ag
SYT
|
+$1.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.78% |
| 2 | Healthcare | 3.98% |
| 3 | Financials | 2.99% |
| 4 | Materials | 2.54% |
| 5 | Communication Services | 1.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IXYS
26
PUT
DELISTED
IXYS Corp
IXYS
| $2.2M | 0.67% |
91,700
+81,600
| +808% | +$1.97M |
|
27
CALL
Humana
HUM
$48B
| $2.03M | 0.62% |
8,200
-500
| -6% | -$123K |
|
|
AAAP
28
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.02M | 0.62% |
+24,700
| New | +$1.92M |
|
|
AAAP
29
PUT
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.02M | 0.62% |
+24,700
| New | +$1.92M |
|
|
KANG
30
PUT
DELISTED
iKang Healthcare Group, Inc.
KANG
| $1.97M | 0.6% |
124,500
-39,300
| -24% | -$568K |
|
|
TNAV
31
DELISTED
Telenav Inc.
TNAV
| $1.65M | 0.51% |
300,547
+131,284
| +78% | +$733K |
|
|
AAAP
32
CALL
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $1.56M | 0.48% |
+19,100
| New | +$1.48M |
|
|
KANG
33
DELISTED
iKang Healthcare Group, Inc.
KANG
| $1.4M | 0.43% |
88,360
-62,940
| -42% | -$909K |
|
34
CALL
AT&T
T
$152B
| $1.35M | 0.42% |
46,075
-16,550
| -26% | -$452K |
|
|
IXYS
35
DELISTED
IXYS Corp
IXYS
| $1.12M | 0.34% |
46,600
+43,800
| +1,564% | +$1.06M |
|
36
CALL
MannKind Corp
MNKD
$1.25B
| $1.06M | 0.32% |
456,200
+32,000
| +8% | +$109K |
|
37
CALL
Precigen
PGEN
$1.76B
| $964K | 0.3% |
83,700
+6,300
| +8% | +$93.8K |
|
|
38
PUT
Precigen
PGEN
$1.76B
| $855K | 0.26% |
74,200
-42,800
| -37% | -$637K |
|
|
RAD
39
CALL
DELISTED
Rite Aid Corporation
RAD
| $655K | 0.2% |
16,620
-5,335
| -24% | -$191K |
|
40
CALL
Williams Companies
WMB
$89.7B
| $546K | 0.17% |
17,900
| – | – |
|
|
41
Precigen
PGEN
$1.76B
| $490K | 0.15% |
42,536
-23,552
| -36% | -$351K |
|
|
FNJN
42
DELISTED
Finjan Holdings, Inc.
FNJN
| $324K | 0.1% |
150,168
| – | – |
|
43
CALL
Nordic American Tanker
NAT
$1.28B
| $311K | 0.1% |
126,600
+23,400
| +23% | +$96.8K |
|
|
44
PUT
AT&T
T
$152B
| $311K | 0.1% |
10,592
+6,620
| +167% | +$181K |
|
45
Angi Inc
ANGI
$248M
| $293K | 0.09% |
+2,802
| New | +$325K |
|
46
Alaunos Therapeutics
TCRT
$5.01M
| $265K | 0.08% |
427
+24
| +6% | +$17.2K |
|
|
47
PUT
Alaunos Therapeutics
TCRT
$5.01M
| $246K | 0.08% |
396
+85
| +27% | +$61.1K |
|
|
RAD
48
PUT
DELISTED
Rite Aid Corporation
RAD
| $242K | 0.07% |
6,150
-675
| -10% | -$24.1K |
|
|
ESPR
49
CALL
DELISTED
Esperion Therapeutics
ESPR
| $237K | 0.07% |
3,600
-16,400
| -82% | -$883K |
|
|
RAD
50
DELISTED
Rite Aid Corporation
RAD
| $201K | 0.06% |
5,095
-1,635
| -24% | -$58.4K |
|
Similar funds
PP
WWA
CQWA
CI
TH
BAH
BWG
AWS
Equitec Proprietary Markets's Q4 2017 Portfolio in Review
As of Q4 2017, Equitec Proprietary Markets held 112 positions worth $326M, down 23% from $425M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Equitec Proprietary Markets withdrew a net $97.2M in Q4 2017, closing 31 positions and reducing 25 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $27.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 5.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Equitec Proprietary Markets opened a new position in GE Aerospace worth $2.95M.
- Equitec Proprietary Markets's largest Q4 2017 buy was GE Aerospace: 35,285 shares worth $2.95M.
- Equitec Proprietary Markets added most to NXP Semiconductors in Q4 2017, an estimated $14.5M increase.
- Equitec Proprietary Markets's biggest Q4 2017 reduction was iKang Healthcare Group, Inc., cutting an estimated $909K.
- Equitec Proprietary Markets fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $27.6M.
- Equitec Proprietary Markets's ten largest holdings make up 69% of its $326M portfolio in Q4 2017.
- Equitec Proprietary Markets opened 14 new positions and closed 31 in Q4 2017.
- Equitec Proprietary Markets's portfolio value fell 23% quarter-over-quarter to $326M.
Based on Equitec Proprietary Markets's 13F filing for Q4 2017, filed 24 Jan 2018.